Literature DB >> 11157699

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice.

D Weiss1, J J Kools, W R Taylor.   

Abstract

BACKGROUND: Angiotensin II may contribute to the development and progression of atherosclerotic lesions because of its growth and proinflammatory effects. We sought to determine whether angiotensin II-induced hypertension would augment and accelerate the development of atherosclerotic lesions in apoE-deficient mice. METHODS AND
RESULTS: Angiotensin II (0.7 mg x kg(-1) x d(-1) SC) was administered to apoE-deficient mice via osmotic minipumps. The animals were placed on either standard chow or an atherogenic diet. After 8 weeks, the mean atherosclerotic lesion area in the descending thoracic and abdominal aortas of animals on a standard chow diet was 0.4+/-0.1% compared with 5.2+/-1.2% in those animals maintained on an atherogenic diet (P:<0.0001). In angiotensin II-treated animals on standard chow, the mean lesion area was increased to 11.0+/-2.3%, which was further increased to 69.9+/-9.4% (P:<0.0001) in angiotensin II-treated animals on an atherogenic diet. Similar findings were obtained when tissues from the ascending aorta were analyzed. At 8 weeks in mice receiving a standard chow diet, angiotensin II dramatically increased the atherosclerotic lesion area by 840+/-83 microm(2) (P:<0.0001). Animals on a high-fat diet had a similar marked increase in lesion area in response to angiotensin II (217+/-19 microm(2), P:<0.0001). In contrast, when hypertension was induced with norepinephrine, only a modest effect on the atherosclerotic lesion area was observed.
CONCLUSIONS: Angiotensin II-induced hypertension specifically increased the development of atherosclerosis in apoE knockout mice. This response was seen in animals receiving either standard chow or an atherogenic diet. These studies demonstrate the profound effect of angiotensin II on the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157699     DOI: 10.1161/01.cir.103.3.448

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  111 in total

1.  Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.

Authors:  Frank M Davis; Debra L Rateri; Anju Balakrishnan; Deborah A Howatt; Dudley K Strickland; Selen C Muratoglu; Christopher M Haggerty; Brandon K Fornwalt; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 4.  Lifestyle effects on hematopoiesis and atherosclerosis.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

5.  A modified sesamol derivative inhibits progression of atherosclerosis.

Authors:  Zhekang Ying; Nisharahmed Kherada; Thomas Kampfrath; Georgeta Mihai; Orlando Simonetti; Rajagopal Desikan; Karuppaiyah Selvendiran; Qinghua Sun; Ouiliana Ziouzenkova; Sampath Parthasarathy; Sanjay Rajagopalan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-23       Impact factor: 8.311

6.  Collagenase-Cleavable Peptide Amphiphile Micelles as a Novel Theranostic Strategy in Atherosclerosis.

Authors:  Deborah D Chin; Christopher Poon; Noah Trac; Jonathan Wang; Jackson Cook; Johan Joo; Zhangjingyi Jiang; Naomi Sulit Sta Maria; Russell E Jacobs; Eun Ji Chung
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

7.  Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice.

Authors:  Rima Elhage; Pierre Gourdy; Laurent Brouchet; Jacek Jawien; Marie-José Fouque; Catherine Fiévet; Xavier Huc; Yara Barreira; Jean Claude Couloumiers; Jean-François Arnal; Francis Bayard
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Cyclic Strain and Hypertension Increase Osteopontin Expression in the Aorta.

Authors:  Christa Caesar; Alicia N Lyle; Giji Joseph; Daiana Weiss; Fadi M F Alameddine; Bernard Lassègue; Kathy K Griendling; W Robert Taylor
Journal:  Cell Mol Bioeng       Date:  2016-12-27       Impact factor: 2.321

9.  Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.

Authors:  Dennis Bruemmer; Alan R Collins; Grace Noh; Wei Wang; Mary Territo; Sarah Arias-Magallona; Michael C Fishbein; Florian Blaschke; Ulrich Kintscher; Kristof Graf; Ronald E Law; Willa A Hsueh
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

10.  Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice.

Authors:  Tracy Henriques; Xuan Zhang; Frederique B Yiannikouris; Alan Daugherty; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.